catalog number :
MBS766842
products full name :
ARSA Rabbit Polyclonal
products short name :
[ARSA]
products name syn :
[ARSA, arylsulfatase A, ASA, Cerebroside sulfatase, MLD]
other names :
[ARSA; Arylsulfatase A; arylsulfatase A; arylsulfatase A; Cerebroside-sulfatase]
products gene name :
[ARSA]
other gene names :
[ARSA; ARSA; MLD; ASA]
uniprot entry name :
ARSA_HUMAN
reactivity :
Human, Mouse, Rat. Other species are not tested.
specificity :
Please decide specifity by homology.
purity :
>=95% as determined by SDS-PAGE. Immunogen Affinity Purified
storage stability :
-20°C for 24 months (Avoid repeated freeze / thaw cycles.)
tested application :
ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC)
app notes :
WB: 1:500-1:2000. IHC: 1:20-1:200
image1 heading :
Immunohistochemistry (IHC)
image2 heading :
SDS-PAGE
other info1 :
Immunogen: Arylsulfatase A
other info2 :
Calculated MW: 56kd. Buffer: PBS with 0.02% sodium azide and 50% glycerol pH 7.3
products description :
Hydrolyzes cerebroside sulfate
ncbi acc num :
CAG30269.1
ncbi pathways :
Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation Pathway (1268702); Glycosphingolipid Metabolism Pathway (1270099); Lysosome Pathway (99052); Lysosome Pathway (96865); Metabolism Pathway (1269956); Metabolism Of Lipids And Lipoproteins Pathway (1270001); Metabolism Of Proteins Pathway (1268677); Post-translational Protein Modification Pathway (1268701); Sphingolipid Metabolism Pathway (82994); Sphingolipid Metabolism Pathway (1270097)
ncbi summary :
The protein encoded by this gene hydrolyzes cerebroside sulfate to cerebroside and sulfate. Defects in this gene lead to metachromatic leucodystrophy (MLD), a progressive demyelination disease which results in a variety of neurological symptoms and ultimately death. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Dec 2010]
uniprot summary :
ARSA: Hydrolyzes cerebroside sulfate. Defects in ARSA are a cause of leukodystrophy metachromatic (MLD). MLD is a disease due to a lysosomal storage defect. It is characterized by intralysosomal storage of cerebroside-3-sulfate in neural and non-neural tissues, with a diffuse loss of myelin in the central nervous system. Progressive demyelination causes a variety of neurological symptoms, including gait disturbances, ataxias, optical atrophy, dementia, seizures, and spastic tetraparesis. Three forms of the disease can be distinguished according to the age at onset: late- infantile, juvenile and adult. Arylsulfatase A activity is defective in multiple sulfatase deficiency (MSD). A clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay. Arylsulfatase A activity is impaired in multiple sulfatase deficiency due to mutations in SUMF1. SUMF1 mutations result in defective post-translational modification of ARSA at residue Cys- 69 that is not converted to 3-oxoalanine. Belongs to the sulfatase family. Protein type: Lipid Metabolism - sphingolipid; EC 3.1.6.8; Hydrolase. Chromosomal Location of Human Ortholog: 22q13.33. Cellular Component: endoplasmic reticulum lumen; lysosomal lumen; lysosome. Molecular Function: arylsulfatase activity; calcium ion binding; cerebroside-sulfatase activity; protein binding; sulfuric ester hydrolase activity. Biological Process: glycosphingolipid metabolic process; post-translational protein modification. Disease: Metachromatic Leukodystrophy